Total Payments
$3,118
2024 Payments
$732.82
Companies
29
Transactions
221
Medicare Patients
1,406
Medicare Billing
$110,992
Payment Breakdown by Category
Food & Beverage$3,118 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,118 | 221 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $927.16 | 58 | $0 (2024) |
| ABBVIE INC. | $872.16 | 85 | $0 (2024) |
| Astellas Pharma US Inc | $201.12 | 12 | $0 (2024) |
| Abbott Laboratories | $164.98 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $117.90 | 8 | $0 (2022) |
| PFIZER INC. | $111.31 | 6 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $105.83 | 4 | $0 (2022) |
| Novo Nordisk Inc | $100.12 | 7 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.03 | 3 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $45.25 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $732.82 | 48 | GlaxoSmithKline, LLC. ($263.17) |
| 2023 | $835.96 | 61 | GlaxoSmithKline, LLC. ($316.96) |
| 2022 | $913.21 | 64 | GlaxoSmithKline, LLC. ($272.78) |
| 2021 | $636.39 | 48 | AbbVie Inc. ($212.75) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: NEUROLOGY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: VACCINES | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Oncology | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes Care | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: NEUROLOGY | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 07/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 352 | 442 | $71,741 | $26,500 |
| 2022 | 10 | 336 | 507 | $75,687 | $26,357 |
| 2021 | 11 | 361 | 485 | $80,391 | $30,901 |
| 2020 | 10 | 357 | 505 | $87,330 | $27,234 |
Total Patients
1,406
Total Services
1,939
Medicare Billing
$110,992
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 137 | $28,222 | $9,232 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $15,250 | $6,258 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 77 | $10,780 | $3,777 | 35.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $9,129 | $2,916 | 31.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 31 | 31 | $3,286 | $2,226 | 67.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 41 | $1,722 | $1,189 | 69.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 23 | 36 | $1,296 | $342.72 | 26.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $462.00 | $318.89 | 69.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 16 | $784.00 | $123.77 | 15.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 15 | $810.00 | $116.89 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 193 | $39,758 | $12,431 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $13,250 | $5,597 | 42.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 15 | $8,055 | $2,485 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 55 | $7,700 | $2,371 | 30.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 26 | 27 | $2,862 | $1,844 | 64.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 31 | $1,302 | $848.04 | 65.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $462.00 | $301.92 | 65.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 32 | $1,152 | $300.35 | 26.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 22 | $1,078 | $173.21 | 16.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 68 | $68.00 | $5.06 | 7.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 194 | $39,964 | $13,892 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 57 | 57 | $14,250 | $6,157 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 67 | $9,380 | $3,485 | 37.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 34 | 35 | $3,710 | $2,276 | 61.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 11 | 11 | $5,907 | $1,989 | 33.7% |
About Dwayne Labatut, N.P
Dwayne Labatut, N.P is a Family healthcare provider based in Gonzales, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760462782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dwayne Labatut, N.P has received a total of $3,118 in payments from pharmaceutical and medical device companies, with $732.82 received in 2024. These payments were reported across 221 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,118).
As a Medicare-enrolled provider, Labatut has provided services to 1,406 Medicare beneficiaries, totaling 1,939 services with total Medicare billing of $110,992. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Gonzales, LA
- Active Since 01/17/2006
- Last Updated 12/29/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1760462782
Products in Payments
- TRELEGY ELLIPTA (Drug) $714.88
- VRAYLAR (Drug) $443.90
- UBRELVY (Drug) $219.56
- QULIPTA (Drug) $208.70
- XARELTO (Drug) $117.90
- FREESTYLE LIBRE 3 (Device) $114.64
- AREXVY (Drug) $113.55
- SUNOSI (Drug) $105.83
- SHINGRIX (Biological) $98.73
- Veozah (Drug) $87.21
- Myrbetriq (Drug) $83.17
- NURTEC ODT (Drug) $81.14
- ELIQUIS (Drug) $68.50
- Ozempic (Drug) $43.10
- NEXLETOL (Drug) $40.20
- PREMARIN (Drug) $39.35
- Kerendia (Drug) $35.67
- VYEPTI (Biological) $34.27
- VOQUEZNA (Drug) $34.05
- FREESTYLE LIBRE (Device) $33.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Gonzales
Darlene Bonadona, Fnp, FNP
Family — Payments: $7,719
Family $7,719
Gina Ragusa, N.p, N.P
Family — Payments: $6,504
Family $6,504
Kayla Aucoin, Np, NP
Family — Payments: $6,136
Family $6,136
Mr. Marcus Rovira, N.p, N.P
Family — Payments: $4,755
Family $4,755
Karen Skidmore, Fnp-C, FNP-C
Family — Payments: $4,065
Family $4,065
Tisha Dooley, Cfnp, CFNP
Family — Payments: $3,970
Family $3,970